June 26, 2020
Lead ‘OncoMimics’ candidate EO2401 planned to start first clinical trials for Glioblastoma and Adrenal Tumors during mid-2020 Paris, France and Cambridge, MA, USA – June 25, 2020 ENTEROME SA, a clinical-stage biopharmaceutical company leveraging its unique knowledge  of the microbiome-immunoinflammation axis to develop next-generation therapeutics, today announces a new financing totaling €46.3 million ($52.6million) to...


Experienced neuroscientist at the helm of The Brain Prize
30. June 2020
Eight promising young researchers receive Lundbeck Foundation Fellowships
16. June 2020
Denmark Gets Its First Master’s Degree Programme in Neuroscience
4. June 2020


Lundbeckfonden Ventures

Lundbeckfonden Emerge